Skip to main content
Premium Trial:

Request an Annual Quote

Lawrence Bruder, Todd Christian, Lalit Dhir, Trevor Bell, ForteBio



Guava Technologies said last week that it has promoted Lawrence Bruder to the position of CEO (see story, this issue).

Bruder served as Guava's chief operating officer and president since July, when he was promoted to the position. Prior to that, he served as vice president of corporate development and worldwide marketing. He has held vice-president-level positions at Applied Biosystems and Becton Dickinson, and has held various marketing, sales, and product management positions with Leica and Olympus. He holds a master of management degree from Kellogg Management School at Northwestern University, and a BS from Rochester Institute of Technology.

Guava also hired Todd Christian as vice president, commercial operations, and Lalit Dhir as vice president of corporate development and strategic marketing.

Christian previously was served various roles in product development, program management, and global marketing across multiple business units at Applied Biosystems, and served as general manager of ABI's cell biology incubator. Prior to this, he was a general manager for BD Biosciences' Canadian operations. He also has served as director or program management, product development, custom products, and marketing with BD Biosciences. He holds a BA in biology from Hamilton College.

Dhir joined Guava from BD Biosciences, where he led strategy planning and corporate development. He also served as manager of business development at BD's Pharmingen division. He holds an MBA from San Diego State University, and an MS and BS in biochemistry from Panjab University in India.

Trevor Bell, Genetix Group's current chief operating officer, will be resigning from the Board of Directors on Jan. 11, 2006, the company said last week.

According to Genetix, the departure follows changes to the board that will make the role of a chief operating officer redundant.


ForteBio announced last week the introduction of its first product — the Octet System for label-free, real-time detection and analysis of molecular interactions.

The Octet System is based on a proprietary technique called BioLayer Interferometry. It incorporates a sensitive optical detector and a series of application-specific biosensor consumables. According to ForteBio, the biosensors provide a way to make critical measurements even in crude samples, at early stages in antibody development.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.